Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Institut du Cancer de Montpellier - Val d'Aurelle
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
Imperial College London
Stanford University
Grupo Espanol de Tumores Neuroendocrinos
University of Iowa
Melanoma and Skin Cancer Trials Limited
Fundación de investigación HM
Sociedad Española de Medicina Nuclear e Imagen Molecular